0001562180-22-007175.txt : 20221012 0001562180-22-007175.hdr.sgml : 20221012 20221012183118 ACCESSION NUMBER: 0001562180-22-007175 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221003 FILED AS OF DATE: 20221012 DATE AS OF CHANGE: 20221012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUGIN ROBERT J CENTRAL INDEX KEY: 0001232505 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41477 FILM NUMBER: 221307668 MAIL ADDRESS: STREET 1: C/O THE MEDICINES CO STREET 2: 8 CAMPUS DR CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Ltd. CENTRAL INDEX KEY: 0001935979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 FORMER COMPANY: FORMER CONFORMED NAME: Biohaven Research Ltd. DATE OF NAME CHANGE: 20220629 4/A 1 primarydocument.xml PRIMARY DOCUMENT X0306 4/A 2022-10-03 2022-10-05 false 0001935979 Biohaven Ltd. BHVN 0001232505 HUGIN ROBERT J C/O BIOHAVEN LTD. 215 CHURCH STREET NEW HAVEN CT 06510 true false false false Common Shares 2022-10-03 4 F false 12959.00 7.50 D 12959.00 D These shares were withheld by the Issuer in connection with share settlement to cover the cost of the stock options. This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that 3,263 shares were withheld by the Issuer in connection with the share settlement to cover the cost of the stock options; however, as reflected in this amendment, 9,790 shares were withheld by the Issuer in connect with the share settlement to cover the cost of the stock options. There were no other changes made to the information in the Original Form 4. /s/ George Clark, Attorney-in-Fact 2022-10-12